FIELD: chemistry.
SUBSTANCE: invention relates to low-molecular derivatives of peptides which are used for preparing a pharmaceutical agent which inhibits laminin/nidogen reaction.
EFFECT: increased effectiveness of compounds.
2 cl, 12 dwg, 2 tbl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LOW-MOLECULAR PEPTIDE DERIVATIVES AS INHIBITORS IN INTERACTION LAMININE/NIDOGEN | 2000 |
|
RU2262509C2 |
| ACETIC ACID DERIVATIVES OR HYDRATES THEREOF, OR SOLVATES THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 1991 |
|
RU2072359C1 |
| DERIVATIVES OF HYDRAZINE OR THEIR SALTS, PHARMACEUTICAL AGENT, AMINOALKYLHYDRAZINES OR THEIR SALTS | 1992 |
|
RU2092492C1 |
| METHOD OF FERMENTATIVE PRODUCTION OF PEPTIDES | 0 |
|
SU1378785A3 |
| SUBSTITUTED 5-MEMBERED HETEROCYCLES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2151143C1 |
| ANTIVIRAL SUBSTRATE ISOSTER ESTERS OF ASPARTATE PROTEASE OR THEIR SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL PREPARATION AND COMPOSITION | 1995 |
|
RU2164229C2 |
| NOVEL ANALOGUES OF GLUCAGON-LIKE PEPTIDE, COMPOSITION AND METHOD OF USE | 2010 |
|
RU2557301C2 |
| NOVEL ANTIBACTERIAL MEDICATIONS FOR TREATMENT OF GRAM-POSITIVE INFECTIONS | 2009 |
|
RU2512396C2 |
| GLYCINE DERIVATIVES OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS SHOWING CAPABILITY TO INHIBIT FIBRINOGEN BINDING IN FIBRINOGEN PLATELET RECEPTOR | 1990 |
|
RU2024549C1 |
| SULFONEAMIDOCARBOXAMIDES, THEIR HYDRATES AND PHYSIOLOGICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION ON SAID | 1993 |
|
RU2133739C1 |
